Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Antibody-drug Conjugate market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Antibody-drug Conjugate market. Detailed analysis of key players, along with key growth strategies adopted by Antibody-drug Conjugate industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Synthon Holding BV
Agensys
Sanofi
Concortis Biotherapeutics
Celldex Therapeutics
By Type:
Adcetris
Kadcyla
By End-User:
Breast Cancer
Lymphoma
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibody-drug Conjugate Market
-
1.3 Market Segment by Type
-
1.3.1 China Antibody-drug Conjugate Market Size and Growth Rate of Adcetris from 2016 to 2027
-
1.3.2 China Antibody-drug Conjugate Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Antibody-drug Conjugate Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 China Antibody-drug Conjugate Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antibody-drug Conjugate Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antibody-drug Conjugate by Major Types
-
3.4.1 Market Size and Growth Rate of Adcetris
-
3.4.2 Market Size and Growth Rate of Kadcyla
4 Segmentation of Antibody-drug Conjugate Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antibody-drug Conjugate by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antibody-drug Conjugate in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Antibody-drug Conjugate in Lymphoma
5 Market Analysis by Regions
-
5.1 China Antibody-drug Conjugate Production Analysis by Regions
-
5.2 China Antibody-drug Conjugate Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Antibody-drug Conjugate Landscape Analysis
-
6.1 North China Antibody-drug Conjugate Landscape Analysis by Major Types
-
6.2 North China Antibody-drug Conjugate Landscape Analysis by Major End-Users
7 Central China Antibody-drug Conjugate Landscape Analysis
-
7.1 Central China Antibody-drug Conjugate Landscape Analysis by Major Types
-
7.2 Central China Antibody-drug Conjugate Landscape Analysis by Major End-Users
8 South China Antibody-drug Conjugate Landscape Analysis
-
8.1 South China Antibody-drug Conjugate Landscape Analysis by Major Types
-
8.2 South China Antibody-drug Conjugate Landscape Analysis by Major End-Users
9 East China Antibody-drug Conjugate Landscape Analysis
-
9.1 East China Antibody-drug Conjugate Landscape Analysis by Major Types
-
9.2 East China Antibody-drug Conjugate Landscape Analysis by Major End-Users
10 Northeast China Antibody-drug Conjugate Landscape Analysis
-
10.1 Northeast China Antibody-drug Conjugate Landscape Analysis by Major Types
-
10.2 Northeast China Antibody-drug Conjugate Landscape Analysis by Major End-Users
11 Southwest China Antibody-drug Conjugate Landscape Analysis
-
11.1 Southwest China Antibody-drug Conjugate Landscape Analysis by Major Types
-
11.2 Southwest China Antibody-drug Conjugate Landscape Analysis by Major End-Users
12 Northwest China Antibody-drug Conjugate Landscape Analysis
-
12.1 Northwest China Antibody-drug Conjugate Landscape Analysis by Major Types
-
12.2 Northwest China Antibody-drug Conjugate Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Synthon Holding BV
-
13.1.1 Synthon Holding BV Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Agensys
-
13.2.1 Agensys Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Sanofi
-
13.3.1 Sanofi Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Concortis Biotherapeutics
-
13.4.1 Concortis Biotherapeutics Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Celldex Therapeutics
-
13.5.1 Celldex Therapeutics Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Antibody-drug Conjugate Market Size and Growth Rate of Adcetris from 2016 to 2027
-
Figure China Antibody-drug Conjugate Market Size and Growth Rate of Kadcyla from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Antibody-drug Conjugate Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure China Antibody-drug Conjugate Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Antibody-drug Conjugate Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antibody-drug Conjugate Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antibody-drug Conjugate
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antibody-drug Conjugate by Different Types from 2016 to 2027
-
Table Consumption Share of Antibody-drug Conjugate by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Adcetris
-
Figure Market Size and Growth Rate of Kadcyla
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antibody-drug Conjugate by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antibody-drug Conjugate by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Lymphoma
-
Table China Antibody-drug Conjugate Production by Regions
-
Table China Antibody-drug Conjugate Production Share by Regions
-
Figure China Antibody-drug Conjugate Production Share by Regions in 2016
-
Figure China Antibody-drug Conjugate Production Share by Regions in 2021
-
Figure China Antibody-drug Conjugate Production Share by Regions in 2027
-
Table China Antibody-drug Conjugate Consumption by Regions
-
Table China Antibody-drug Conjugate Consumption Share by Regions
-
Figure China Antibody-drug Conjugate Consumption Share by Regions in 2016
-
Figure China Antibody-drug Conjugate Consumption Share by Regions in 2021
-
Figure China Antibody-drug Conjugate Consumption Share by Regions in 2027
-
Table North China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table North China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure North China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure North China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure North China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table North China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table North China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure North China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure North China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure North China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table Central China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table Central China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure Central China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure Central China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure Central China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table Central China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table Central China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure Central China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure Central China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table South China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table South China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure South China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure South China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure South China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table South China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table South China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure South China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure South China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure South China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table East China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table East China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure East China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure East China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure East China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table East China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table East China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure East China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure East China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure East China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table Northeast China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table Northeast China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table Northeast China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table Northeast China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure Northeast China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table Southwest China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table Southwest China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table Southwest China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table Southwest China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure Southwest China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table Northwest China Antibody-drug Conjugate Consumption by Types from 2016 to 2027
-
Table Northwest China Antibody-drug Conjugate Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by Types in 2016
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by Types in 2021
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by Types in 2027
-
Table Northwest China Antibody-drug Conjugate Consumption by End-Users from 2016 to 2027
-
Table Northwest China Antibody-drug Conjugate Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by End-Users in 2016
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by End-Users in 2021
-
Figure Northwest China Antibody-drug Conjugate Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Synthon Holding BV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Holding BV
-
Figure Sales and Growth Rate Analysis of Synthon Holding BV
-
Figure Revenue and Market Share Analysis of Synthon Holding BV
-
Table Product and Service Introduction of Synthon Holding BV
-
Table Company Profile and Development Status of Agensys
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agensys
-
Figure Sales and Growth Rate Analysis of Agensys
-
Figure Revenue and Market Share Analysis of Agensys
-
Table Product and Service Introduction of Agensys
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Concortis Biotherapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Concortis Biotherapeutics
-
Figure Sales and Growth Rate Analysis of Concortis Biotherapeutics
-
Figure Revenue and Market Share Analysis of Concortis Biotherapeutics
-
Table Product and Service Introduction of Concortis Biotherapeutics
-
Table Company Profile and Development Status of Celldex Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celldex Therapeutics
-
Figure Sales and Growth Rate Analysis of Celldex Therapeutics
-
Figure Revenue and Market Share Analysis of Celldex Therapeutics
-
Table Product and Service Introduction of Celldex Therapeutics
-
